Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2011
04/27/2011CN102030821A Human placental anti-aging active protein as well as separation method and application thereof
04/27/2011CN102030820A Polypeptide used for preventing and treating diabetes and lipid metabolic disturbance
04/27/2011CN101487006B Cloning and function of Chinese cabbage LRR disease-resistant protein gene BcLRR
04/27/2011CN101426907B Cloning and expression of a novel phytase
04/27/2011CN101270155B Method for assembling foot and mouth disease virus hollow capsid in insect with acidproof improvement
04/27/2011CN101260140B Method for preparing protein filling material for leather preparation by using animal hair as raw material
04/27/2011CN101250528B Domestic pig proliferation inducing ligand cDNA as well as clone method and recombinant uses thereof
04/26/2011US7932444 Tomato line PSQ23-2258
04/26/2011US7932443 Tomato line FIR10-8086
04/26/2011US7932441 Tomato line PSQ24-2082
04/26/2011US7932433 Plant cyclopropane fatty acid synthase genes, proteins, and uses thereof
04/26/2011US7932432 Seedy 1 nucleic acids for making plants having changed growth characteristics
04/26/2011US7932375 Kits for detecting rank nucleic acids
04/26/2011US7932374 Expression vector comprising nucleotide sequences coding vascular tissue-specific outer membrane protein promoter for use as regulatory tool in controlling heterologus and endogenous gene expression
04/26/2011US7932373 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
04/26/2011US7932371 Tick octopamine receptor nucleic acid molecules
04/26/2011US7932365 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
04/26/2011US7932364 Extended half life; reduced clearance and immunogenicity; industrial scale production; cells, expression cassettes
04/26/2011US7932363 Antibody that binds human eosinophil-derived basic protein
04/26/2011US7932362 Antibodies to NRIF3 proteins
04/26/2011US7932360 Recombinant production of mixtures of antibodies
04/26/2011US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies
04/26/2011US7932357 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells
04/26/2011US7932356 Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
04/26/2011US7932355 Virally-safe factor VIII with a low content of higher multimers
04/26/2011US7932352 Semaphorin genes (I)
04/26/2011US7932351 Soluble kinase receptor for use in identifying modulators to treat and prevent cell proliferative, respiratory, kidney and liver disorders
04/26/2011US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
04/26/2011US7932229 Peptides for treatment of tumors/cancer
04/26/2011US7932227 Lacritin-syndecan fusion proteins
04/26/2011US7932226 NFκB transcriptional activity inhibitory agent and anti-inflammatory agent and a steroid action enhancing agent
04/26/2011US7932225 Glue composition for lung volume reduction
04/26/2011US7932085 Modified leukotoxin gene and protein
04/26/2011US7932080 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
04/26/2011US7932071 Thermostable ribonuclease H from Archaeoglobus profundus
04/26/2011US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof
04/26/2011US7932058 Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
04/26/2011US7932056 Crustaceans as production systems for therapeutic proteins
04/26/2011US7932055 Soluble heterodimeric CD94/NKG2 receptors fusion proteins
04/26/2011US7932053 Forming triple helical, collagenous protein; directed polypeptide evolution
04/26/2011US7931907 Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
04/26/2011US7931905 Cynomolgus gp80 receptor and uses thereof
04/26/2011US7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
04/26/2011US7931897 Therapeutic agent for hematopoietic tumors
04/26/2011US7931893 A pseudotyped feline immunodeficiency virus virion; transfection; expression vectors packaged in packaging cells to generate high titer recombinant virus stocks; gene therapy
04/26/2011CA2531969C Protein-refolding material
04/26/2011CA2463689C Primers and method of detecting bacteria
04/26/2011CA2446461C Substituted cyclohexane-1,4-diamine derivatives
04/26/2011CA2446112C A method for regulating immune function in primates using the foxp3 protein
04/26/2011CA2365259C Banana and melon promoters for expression of transgenes in plants
04/26/2011CA2362513C A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
04/26/2011CA2351274C Isolated cocoon silk protein from simulium vittatum and nucleic acids encoding such protein
04/26/2011CA2337971C Novel anti-diabetic peptides
04/26/2011CA2264012C Compositions and methods for polynucleotide delivery
04/26/2011CA2215394C Il-17 receptor
04/26/2011CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins
04/21/2011WO2011047340A1 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
04/21/2011WO2011047324A1 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites
04/21/2011WO2011047316A1 Nucleic acid sequences encoding expandable hiv mosaic proteins
04/21/2011WO2011047274A1 Conjugative plasmids from clostridium botulinum and methods of use thereof
04/21/2011WO2011047257A1 Compositions and methods for producing cyclic peptoid libraries
04/21/2011WO2011047204A1 Method of treating memory disorders and enhancing memory using igf-ii compounds
04/21/2011WO2011047180A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
04/21/2011WO2011047073A2 Assessing rheumatoid arthritis
04/21/2011WO2011047065A1 Recombinant human cc10 protein for treatment of influenza
04/21/2011WO2011046996A2 Consensus sequence for influenza a virus
04/21/2011WO2011046925A1 Respiratory syncytial virus (rsv) virus-like particles (vlps)
04/21/2011WO2011046922A1 Use of nibp polypeptides
04/21/2011WO2011046855A1 Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
04/21/2011WO2011046812A1 Phospholipases, nucleic acids encoding them and methods for making and using them
04/21/2011WO2011046623A2 Hiv-1 antibodies
04/21/2011WO2011046622A2 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
04/21/2011WO2011046585A1 Thermophilic mannanohydrolase and fracturing fluids containing the same
04/21/2011WO2011046521A1 Self-assembled structures composed of single polypeptide comprising at least three coiled-coil forming elements
04/21/2011WO2011046520A1 Polypeptide material with adjustable pore properties
04/21/2011WO2011046519A1 Polypeptide material composed of elastin-like segments and coiled coil segments
04/21/2011WO2011046462A1 Composition for treatment of multiple sclerosis
04/21/2011WO2011046214A1 Peptide binding to methylated dna
04/21/2011WO2011046160A1 Method for screening of substance capable of preventing virus infection, and agent for preventing virus infection
04/21/2011WO2011045612A1 Mycobacterial vaccines
04/21/2011WO2011045573A2 Staphylococcal antigens
04/21/2011WO2011045113A2 Competitive exclusion compositions and methods
04/21/2011WO2011045079A1 Hepatitis b virus specific human antibodies
04/21/2011WO2011044698A1 Multi epitope vaccine for poultry
04/21/2011WO2011044694A1 Blackleg resistance gene
04/21/2011WO2011044654A1 Phosphorylation of the estrogen receptor alpha serine 282 as a marker for endocrine therapies in breast cancer
04/21/2011WO2011044636A1 Na-k pump modulation
04/21/2011WO2011027342A3 Multi-site modified sp1 polypeptides and uses thereof
04/21/2011WO2011026132A3 Methods and compositions for the inhibition of transplant rejection
04/21/2011WO2011011273A9 The use of dimerization domain component stacks to modulate plant architecture
04/21/2011WO2010144678A3 Generation of vascularized human heart tissue and uses thereof
04/21/2011WO2010144231A3 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
04/21/2011WO2010138851A3 E-cadherin as a biomarker of gastroesophageal reflux disease
04/21/2011WO2010138814A3 Disrupting fcrn-albumin interactions
04/21/2011WO2010138794A3 Regulation of sodium channels by plunc proteins
04/21/2011WO2010138637A3 Fibromodulin peptide
04/21/2011WO2010135655A3 Human skin substitutes expressing il-12
04/21/2011WO2010135639A3 Compositions and methods for promoting beta cell maturity
04/21/2011WO2010135585A3 Engineered type iv pilin of clostridium difficile
04/21/2011WO2010135391A3 An improved method for diagnosing or predicting short stature in humans